Monthly Archives: November 2025

Three new members have been co-opted to the Community Pharmacy England Committee to better reflect the make-up of the sector. Following a period as Observers to the Committee, Has Modi, Managing Director of Jardines (UK) Ltd, and Mayank Patel, Superintendent Pharmacist of Pearl Chemist Group, have become the first Members to be nominated by the [...]

The post New representatives join Community Pharmacy England Committee appeared first on Community Pharmacy England.

Pharmacy owners have just over a week left to complete the 2025 workforce survey, which is a mandatory requirement for all pharmacy owners. The NHS Business Services Authority sent an email to pharmacy owners containing a link to the survey in September. In some cases, for example, if you work for a multiple pharmacy group, the [...]

The post One week left to complete the 2025 mandatory workforce survey appeared first on Community Pharmacy England.

From this month, pharmacy owners may notice a difference in their Advance payments, with these payments higher in value than they have been previously. This is because of a change in policy, with several NHS services now being paid on the same date as the early Advance payment for dispensed prescriptions. Community Pharmacy England has [...]

The post Advance Payments Update: Payments now include Flu and Covid-19 activity appeared first on Community Pharmacy England.

Community pharmacies across England are facing intense and unsustainable pressure, with morale at breaking point and patient care increasingly at risk, according to findings from Community Pharmacy England’s 2025 Pharmacy Pressures Survey: Staffing and Morale report. With over 4,300 pharmacy premises and 1,600 staff responding, the survey paints a stark picture of a sector grappling [...]

The post Morale at breaking point as pharmacy staffing crisis deepens appeared first on Community Pharmacy England.

MHRA Class 3 Medicines Recall: Atorvastatin 20mg and 80mg Film-coated Tablets (Sun Pharmaceutical Industries Limited) Drug Alert Number: EL(25)A/48 Date issued: 11 November 2025 Sun Pharma UK Limited are recalling the batches of tablets specified in the table as a precautionary measure due to failing dissolution test results reported during ongoing stability studies. DMRC reference number: DMRC [...]

The post MHRA Class 3 Medicines Recall: Atorvastatin 20mg and 80mg Film-coated Tablets (Sun Pharmaceutical Industries Limited) appeared first on Community Pharmacy England.